| A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci N Rothman, M Garcia-Closas, N Chatterjee, N Malats, X Wu, JD Figueroa, ... Nature genetics 42 (11), 978-984, 2010 | 506 | 2010 |
| European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene T Rafnar, SH Vermeulen, P Sulem, G Thorleifsson, KK Aben, JA Witjes, ... Human molecular genetics 20 (21), 4268-4281, 2011 | 163 | 2011 |
| Breast cancer: a candidate gene approach across the estrogen metabolic pathway C Justenhoven, U Hamann, F Schubert, M Zapatka, CB Pierl, S Rabstein, ... Breast cancer research and treatment 108, 137-149, 2008 | 97 | 2008 |
| Unraveling Ambiguous NAT2 Genotyping Data JAG Agundez, K Golka, C Martinez, S Selinski, M Blaszkewicz, ... Clinical chemistry 54 (8), 1390-1394, 2008 | 89 | 2008 |
| Haemoglobin adducts of acrylonitrile and ethylene oxide in acrylonitrile workers, dependent on polymorphisms of the glutathione transferases GSTT1 and GSTM1 R Thier, J Lewalter, M Kempkes, S Selinski, T Brüning, HM Bolt Archives of toxicology 73, 197-202, 1999 | 79 | 1999 |
| Genetic variants in urinary bladder cancer: collective power of the “wimp SNPs” K Golka, S Selinski, ML Lehmann, M Blaszkewicz, R Marchan, K Ickstadt, ... Archives of toxicology 85, 539-554, 2011 | 76 | 2011 |
| Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk S Selinski, M Blaszkewicz, K Ickstadt, JG Hengstler, K Golka Archives of toxicology 87, 2129-2139, 2013 | 74 | 2013 |
| Susceptibility to urinary bladder cancer: relevance of rs9642880 [T], GSTM1 0/0 and occupational exposure K Golka, M Hermes, S Selinski, M Blaszkewicz, HM Bolt, G Roth, ... Pharmacogenetics and genomics 19 (11), 903-906, 2009 | 73 | 2009 |
| Glycerol-3-phosphate acyltransferase 1 promotes tumor cell migration and poor survival in ovarian carcinoma R Marchan, B Büttner, J Lambert, K Edlund, I Glaeser, M Blaszkewicz, ... Cancer research 77 (17), 4589-4601, 2017 | 65 | 2017 |
| Genetic determinants of steatosis and fibrosis progression in paediatric non‐alcoholic fatty liver disease CA Hudert, S Selinski, B Rudolph, H Bläker, C Loddenkemper, ... Liver international 39 (3), 540-556, 2019 | 64 | 2019 |
| Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype S Selinski, M Blaszkewicz, ML Lehmann, D Ovsiannikov, O Moormann, ... Pharmacogenetics and genomics 21 (10), 673-678, 2011 | 61 | 2011 |
| Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes M Schug, R Stöber, T Heise, H Mielke, U Gundert-Remy, P Godoy, R Reif, ... Archives of toxicology 87, 337-345, 2013 | 59 | 2013 |
| Glycerophospholipid profile in oncogene-induced senescence C Cadenas, S Vosbeck, EM Hein, B Hellwig, A Langer, H Hayen, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2012 | 57 | 2012 |
| ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer IB Petry, E Fieber, M Schmidt, M Gehrmann, S Gebhard, M Hermes, ... Clinical Cancer Research 16 (2), 451-460, 2010 | 57 | 2010 |
| Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industry D Ovsiannikov, S Selinski, ML Lehmann, M Blaszkewicz, O Moormann, ... Journal of Toxicology and Environmental Health, Part A 75 (8-10), 557-565, 2012 | 55 | 2012 |
| Re-investigation of the concordance of human NAT2 phenotypes and genotypes HM Bolt, S Selinski, D Dannappel, M Blaszkewicz, K Golka Archives of toxicology 79, 196-200, 2005 | 54 | 2005 |
| Genome-wide association study yields variants at 20p12. 2 that associate with urinary bladder cancer T Rafnar, P Sulem, G Thorleifsson, SH Vermeulen, H Helgason, ... Human molecular genetics 23 (20), 5545-5557, 2014 | 51 | 2014 |
| Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12. 2 region as a multi-signal locus associated with bladder cancer risk in individuals of … JD Figueroa, CD Middlebrooks, AR Banday, Y Ye, M Garcia-Closas, ... Human molecular genetics 25 (6), 1203-1214, 2016 | 48 | 2016 |
| Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers H Schwender, S Selinski, M Blaszkewicz, R Marchan, K Ickstadt, K Golka, ... PLoS One 7 (12), e51880, 2012 | 42 | 2012 |
| Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer M Schmidt, IB Petry, D Böhm, A Lebrecht, C von Törne, S Gebhard, ... Breast cancer research and treatment 125, 637-646, 2011 | 41 | 2011 |
Klaus GolkaLeibniz Research Centre for Working Environment and Human Factors, IfADo, Dortmund, GermanyVerified email at ifado.de
